Posted by linkadge on February 10, 2007, at 20:17:04
In reply to Re: GSK and Fabre-Kramer make agreement on Gepirone ER, posted by alienatari on February 10, 2007, at 19:25:19
Yeah, I pray they are not toying with us again. This is a treatment option that we deparately need.
A cleaner, more slective buspar could offer many people with either an effective monotherapy for anxiety/depression or a useful adjunctive in depression, schizophrenia, and even parkionsons, or cognative disorders.
Linkadge
poster:linkadge
thread:731652
URL: http://www.dr-bob.org/babble/20070207/msgs/731679.html